[Effects of perfluorodecalin (Fluosol-DC) on tissue oxygenation]. 1976

I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota

UI MeSH Term Description Entries
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005465 Fluorocarbon Polymers Fluorinated Polymer,Fluorinated Polymers,Fluorocarbon Polymer,Fluorocarbon Resin,Fluorocarbon Resins,Fluoropolymers,Fluoropolymer,Polymer, Fluorinated,Polymer, Fluorocarbon,Polymers, Fluorinated,Polymers, Fluorocarbon,Resin, Fluorocarbon,Resins, Fluorocarbon
D005466 Fluorocarbons Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions, and fluorocarbon blood substitutes. Perfluorinated and related polyfluorinated chemicals are referred to as PFAS and are defined as chemicals with at least two adjacent carbon atoms, where one carbon is fully fluorinated and the other is at least partially fluorinated. Fluorocarbon,Fluorocarbon Emulsion,Fluorocarbon Emulsions,Fluorotelomer Phosphate Esters,N-Alkyl Perfluoroalkyl Sulfonamido Carboxylates,PFAS Per- and Polyfluoroalkyl Substances,PFC Perfluorinated Chemicals,PFECAs Perfluoropolyether Carboxylic Acids,Per- and Polyfluoroalkyl Substances,Perfluoroalkane Sulfonamides,Perfluoroalkyl Carboxylates,Perfluoroalkyl Ether Carboxylates,Perfluoroalkyl Polyether Carboxylates,Perfluorocarbon,Perfluorocarbons,Perfluoropolyether Carboxylic Acids,Polyfluorocarbons,Fluorinated Telomer Alcohols,Fluoro-Telomer Alcohols,Polyfluorinated Telomer Alcohols,Telomer Fluorocarbons,Acids, Perfluoropolyether Carboxylic,Alcohols, Fluorinated Telomer,Alcohols, Fluoro-Telomer,Alcohols, Polyfluorinated Telomer,Carboxylates, Perfluoroalkyl,Carboxylates, Perfluoroalkyl Ether,Carboxylates, Perfluoroalkyl Polyether,Carboxylic Acids, Perfluoropolyether,Chemicals, PFC Perfluorinated,Emulsion, Fluorocarbon,Emulsions, Fluorocarbon,Esters, Fluorotelomer Phosphate,Ether Carboxylates, Perfluoroalkyl,Fluoro Telomer Alcohols,Fluorocarbons, Telomer,N Alkyl Perfluoroalkyl Sulfonamido Carboxylates,PFAS Per and Polyfluoroalkyl Substances,Per and Polyfluoroalkyl Substances,Perfluorinated Chemicals, PFC,Phosphate Esters, Fluorotelomer,Polyether Carboxylates, Perfluoroalkyl,Sulfonamides, Perfluoroalkane,Telomer Alcohols, Fluorinated,Telomer Alcohols, Polyfluorinated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
July 1984, Anesthesia and analgesia,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
October 1987, Cancer research,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
January 1988, Biomaterials, artificial cells, and artificial organs,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
November 1995, Biulleten' eksperimental'noi biologii i meditsiny,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
January 1988, Biomaterials, artificial cells, and artificial organs,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
September 1982, Minerva medica,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
January 1986, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
January 2014, Adipocyte,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
March 2011, Medicine and science in sports and exercise,
I Kosugi, and Y Yamaguchi, and T Kitagaki, and Y Kawashima, and H Mizota
September 1989, Heart & lung : the journal of critical care,
Copied contents to your clipboard!